Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Evans John M. −$1.2M CEO sold 5% of stake
  2. Cavanagh Bethany J −$5K SVP, Finance and Treasurer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2020-12-30 Evans John M. CEO Sale −1,121 $88.12 $99K 972,623
2020-12-30 Evans John M. CEO Sale −1,666 $89.41 $149K 970,957
2020-09-30 Ciaramella Giuseppe President & CSO Option exercise +3,731 $0.67 $2K 3,731
2020-09-30 Ciaramella Giuseppe President & CSO Option exercise · Stock Option (Right to Buy) −3,731 269,444
2020-09-18 Burrell Terry-Ann CFO Option exercise +7,309 $13.68 $100K 7,309
2020-09-18 Burrell Terry-Ann CFO Option exercise · Stock Option (Right to Buy) −7,309 382,941
2020-08-07 FMR LLC 10% owner Other acquisition +356,674 356,674
2020-04-16 Evans John M. CEO Option exercise +115,000 $1.03 $118K 993,257
2020-04-16 Evans John M. CEO Option exercise · Stock Option (Right to Buy) −115,000 402,345
2020-02-10 FMR LLC 10% owner Conversion +66,369 66,369
2020-02-10 FMR LLC 10% owner Conversion +4,715,723 4,782,092
2020-02-10 FMR LLC 10% owner Conversion +2,189,820 6,971,912
2020-02-10 FMR LLC 10% owner Conversion · Series B Convertible Preferred Stock −297,620 0
2020-02-10 FMR LLC 10% owner Conversion · Series A-2 Convertible Preferred Stock −21,146,743 0
2020-02-10 FMR LLC 10% owner Conversion · Series A-1 Convertible Preferred Stock −9,819,820 0
2020-02-10 Redmile Group, LLC 10% owner Conversion +1,161,458 1,161,458
2020-02-10 Redmile Group, LLC 10% owner Conversion · Series B Redeemable Convertible Preferred Stock −5,208,333 0
2020-02-10 Ciaramella Giuseppe President & CSO Grant or award · Stock Option (Right to Buy) +510,893 510,893
2020-02-10 COOPER GRAHAM K Director Grant or award · Stock Option (Right to Buy) +31,220 31,220
2020-02-10 Fishman Mark Director Conversion +17,007 17,007

Page 30 of 32 · 630 trades